Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Q2 2020 Earnings Conference Call - Final Transcript

Jul 30, 2020 • 09:30 am ET


Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Q2 2020 Earnings Conference Call - Final Transcript


Loading Event

Loading Transcript


Ladies and gentlemen, thank you for standing by. I am Emma, your Chorus Call operator. Welcome and thank you for joining the Fresenius Medical Care Earnings Call on the Second Quarter 2020 Results. [Operator Instructions]

I would now like to turn the conference over to Dominik, Head of Investor Relations. Please go ahead, sir.

Dominik Heger

Thank you, Emma. We would like to welcome all of you to the Fresenius Medicare earnings call for the second quarter of 2020. We appreciate you joining today despite the markets being a bit in turmoil today. Now it is my very big pleasure as always to start out the call by mentioning our cautionary language that is in our safe harbor statement as well as in our presentation and in all the materials that we have distributed earlier today. For further details concerning risks and uncertainties, please refer to these documents as well as to our SEC filings. We will be hosting a virtual Capital Market Day on October eight and hope all of you sign up for it.

In preparation for this event, we will pause all nonmandatory capital market communication until our CMD. Therefore, please use the opportunity today to ask your questions. [Operator Instructions] It would be great if we could make this work again this time. With us today is, of course, Rice Powell, our CEO and Chairman of the Management Board. Rice will give you some more color around the business development and go through some of the major topics of the quarter. And of course, also with us is Helen Giza, our Chief Financial Officer, who will give you an update on the financials and the outlook.

I will now hand over to Rice. The floor is yours.

Rice Powell

Thank you, Dominik. Hello, everyone. It's great to have you with us today. I do very much appreciate your interest in Fresenius Medical Care. I also hope that you and your families are all very safe and very healthy. Please allow me to recognize the tireless efforts of our employees, both in and outside our clinics, and the dedication that is required to ensure that our patients receive their lifesaving dialysis treatments in a safe, clean environment with the high quality that they have come to expect from Fresenius Medical Care. I cannot thank our employees enough. But for them, where would we be?

As Dominik said, he is joining leading today from Bad Homburg, Helen is in Chicago, and I am in Boston. And it does appear that this virtual world that we're living in is becoming somewhat of a new normal.

Let's hope that fades quickly. Turning to slide four, please. Our strong performance in the second quarter and the first half of this year proves that our core value proposition and the resilience of our business model is well-founded. We are grounded in our vertical integration strategy, and we will continue to do so. Our solid revenue growth did continue in the quarter. We had no support from exchange